MRI ASSESSMENT OF TUMOR SIZE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY

被引：0
|
作者：
Cuccarini, V. [1 ]
Schettino, C. [2 ,3 ]
Acquino, D. [4 ]
Scotti, A. [4 ]
Cuppini, L. [2 ]
Finocchiaro, G. [2 ]
Bruzzone, M. [4 ]
Eoli, M. [5 ]
机构：
[1] Ist Neurol Besta, Unit Neuroradiol, Milan, Italy
[2] Ist Neurol Besta, Uniti Mol Neurooncol, Milan, Italy
[3] Univ Naples 2, Naples, Italy
[4] Ist Neurol Besta, Uniti Neuroradiol, Milan, Italy
[5] Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02.01
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Newly Diagnosed Glioblastoma in Elderly Patients
    Carlen A. Yuen
    Marissa Barbaro
    Aya Haggiagi
    Current Oncology Reports, 2022, 24 : 325 - 334
  • [32] RESPONSE ASSESSMENT USING MULTIPARAMETRIC MRI DURING CHEMORADIATION PREDICTS OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Kim, Michelle
    Aryal, Madhava
    Parmar, Hemant
    Li, Pin
    Schipper, Matthew
    Wahl, Daniel
    Lawrence, Theodore
    Cao, Yue
    NEURO-ONCOLOGY, 2019, 21 : 179 - 179
  • [33] MRI changes in patients with newly diagnosed glioblastoma treated as part of a phase II trial with bavituximab, radiation, and temozolomide.
    Ly, Ina
    Cardona, Jonathan
    Lou, Kevin
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David A.
    Arrillaga-Romany, Isabel
    Forst, Deborah Anne
    Jordan, Justin T.
    Lee, Eudocia Quant
    Dietrich, Jorg
    Nayak, Lakshmi
    Wen, Patrick Y.
    Chukwueke, Ugonma Nnenna
    Batchelor, Tracy
    Curry, William T.
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth Robins
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] TUMOR MARKERS ASSOCIATED WITH INCREASED SURVIVAL IN A PHASE II TRIAL OF DENDRITIC CELL/TUMOR-INITIATING-CELL VACCINE AV-GBM-1 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Bota, Daniela
    Piccioni, David
    Duma, Christopher
    LaRocca, Renato
    Kesari, Santosh
    Carrillo, Jose
    Hsu, Frank
    Kong, Xiao-Tang
    Abedi, Mehrdad
    Aiken, Robert
    Taylor, Thomas
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A357 - A357
  • [35] A Phase I Trial of Tumor Associated Antigen-Pulsed Dendritic Cell Immunotherapy for Patients with Glioblastoma
    Yu, John S.
    Rudnick, Jeremy
    Chu, Ray M.
    Mazer, Mia
    Wang, Hongqiang
    Serrano, Natalia
    Francisco, Maritess
    Wheeler, Christopher J.
    Singh, Manish
    Black, Keith L.
    Phuphanich, Surasak
    NEUROSURGERY, 2009, 65 (02) : 425 - 426
  • [36] Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI
    K. Ina Ly
    Bella Vakulenko-Lagun
    Kyrre E. Emblem
    Yangming Ou
    Xiao Da
    Rebecca A. Betensky
    Jayashree Kalpathy-Cramer
    Dan G. Duda
    Rakesh K. Jain
    Andrew S. Chi
    Scott R. Plotkin
    Tracy T. Batchelor
    Gregory Sorensen
    Bruce R. Rosen
    Elizabeth R. Gerstner
    Scientific Reports, 9
  • [37] The Impact of Intraoperative MRI and Other Factors on Survival for Patients With Newly Diagnosed Glioblastoma. A Multicenter Assessment of Over 800 Patients
    Shah, Amar S.
    Sylvester, Peter
    Vellimana, Ananth K.
    Dunn, Gavin P.
    Evans, John
    Jensen, Randy L.
    Honeycutt, John H.
    Sutherland, Garnette R.
    Cahill, Daniel P.
    Shah, Mitesh V.
    Abram, Steven R.
    Oswood, Mark C.
    Kim, Albert H.
    Leuthardt, Eric C.
    Dowling, Joshua L.
    Rich, Keith M.
    Dacey, Ralph G.
    Zipfel, Gregory J.
    Tao, Yu
    Chicoine, Michael R.
    NEUROSURGERY, 2018, 65 : 120 - 121
  • [38] INCREASED FATIGUE ASSOCIATED WITH TUMOR PROGRESSION IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS
    Peters, Katherine B.
    Affronti, Mary Lou
    Threatt, Stevie
    Healy, Patrick
    Herndon, James E., II
    Lipp, Eric S.
    Panta, Sujata
    Randazzo, Dina
    Friedman, Henry S.
    Desjardins, Annick
    NEURO-ONCOLOGY, 2017, 19 : 170 - 170
  • [39] COMBINATION OF TUMOR TREATING FIELDS (TTFIELDS) AND RADIOCHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Avgoustidou, M.
    Mahlknecht, U.
    NEURO-ONCOLOGY, 2018, 20 : 235 - 235
  • [40] Tumor Treating Fields (TTFields) in combination with radiochemotherapy in patients with newly diagnosed glioblastoma
    Avgoustidou, M.
    Mahlknecht, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S59 - S59
12345